PLTR vs. NOVO-B.CO
PLTR (Palantir Technologies Inc.) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. PLTR operates in Software - Infrastructure (Technology), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 5 years, PLTR returned 41.37%/yr vs 18.06%/yr for NOVO-B.CO. At a 0.07 correlation, their price movements are largely independent.
Performance
PLTR vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
PLTR is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, PLTR achieves a -23.22% return, which is significantly lower than NOVO-B.CO's -14.86% return.
PLTR
- 1D
- 0.69%
- 1M
- -0.97%
- YTD
- -23.22%
- 6M
- -24.81%
- 1Y
- 6.85%
- 3Y*
- 108.67%
- 5Y*
- 41.37%
- 10Y*
- —
NOVO-B.CO
- 1D
- 0.00%
- 1M
- -8.03%
- YTD
- -14.86%
- 6M
- -6.49%
- 1Y
- -41.18%
- 3Y*
- 5.14%
- 5Y*
- 18.06%
- 10Y*
- 16.29%
PLTR vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PLTR Palantir Technologies Inc. | -23.22% | 135.03% | 340.48% | 167.45% | -64.74% | -22.68% | 135.50% |
NOVO-B.CO Novo Nordisk A/S | -14.86% | -39.54% | -15.04% | 214.95% | 23.90% | 65.39% | 0.45% |
Correlation
The correlation between PLTR and NOVO-B.CO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2020 | 0.07 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PLTR vs. NOVO-B.CO — Risk / Return Rank
PLTR
NOVO-B.CO
PLTR vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Palantir Technologies Inc. (PLTR) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PLTR | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.88 | ||
| Sortino ratioReturn per unit of downside risk | +1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 0.88 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 0.18 | -0.76 | +0.94 |
| Martin ratioReturn relative to average drawdown | 0.33 | -1.14 | +1.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PLTR | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.14 | -0.75 | +0.88 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.64 | 0.31 | +0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.36 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.86 | 0.66 | +0.20 |
Drawdowns
PLTR vs. NOVO-B.CO - Drawdown Comparison
The maximum PLTR drawdown since its inception was -84.62%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for PLTR and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| PLTR | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.62% | -74.86% | -9.76% |
Max Drawdown (1Y)Largest decline over 1 year | -38.19% | -54.88% | +16.69% |
Max Drawdown (3Y)Largest decline over 3 years | -40.61% | -74.86% | +34.25% |
Max Drawdown (5Y)Largest decline over 5 years | -79.14% | -74.86% | -4.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.86% | — |
Current DrawdownCurrent decline from peak | -34.13% | -69.56% | +35.43% |
Average DrawdownAverage peak-to-trough decline | -40.29% | -12.33% | -27.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.71% | 36.42% | -15.71% |
Volatility
PLTR vs. NOVO-B.CO - Volatility Comparison
Palantir Technologies Inc. (PLTR) has a higher volatility of 17.24% compared to Novo Nordisk A/S (NOVO-B.CO) at 11.16%. This indicates that PLTR's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PLTR | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.24% | 11.16% | +6.08% |
Volatility (6M)Calculated over the trailing 6-month period | 38.35% | 40.40% | -2.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.93% | 55.90% | -4.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.44% | 58.91% | +6.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.81% | 45.47% | +24.34% |
Dividends
PLTR vs. NOVO-B.CO - Dividend Comparison
PLTR has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 4.35% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
PLTR Palantir Technologies Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PLTR vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Palantir Technologies Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PLTR and NOVO-B.CO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for PLTR and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer